Danielle M.J. Curfs
Ms. Curfs studied Environmental Health Sciences at Maastricht University (Netherlands) and obtained her BSc in 1999. She obtained her PhD in Toxicology and Cardiovascular Diseases in 2004 and continued as a postdoctoral research fellow setting up high-throughput screening methods in a collaboration between former pharmaceutical company Organon, Maastricht University and the Dutch government. In 2009, she transferred to Royal DSM and started working as a project manager in the public-private collaboration BioMedical Materials Program. Here she managed a project portfolio of M€50 in the fields of cardiovascular, nephrology and drug delivery. In 2014, she switched to DSM’s Innovation Center as the program director of DSM’s global competence program on Health. Simultaneously she was involved in setting up the biomedical program of the public-private Institute for Science and Technology (InSciTe). As of 2016, she is responsible for InSciTe’s Biomedical program and dedicated her time on developing a matrix concept to accelerate (bio)medical innovations towards market and patient. This matrix concept is the foundation of the Medace company.